CCTGMA.32, a phase III randomized double-blind placebo controlled adjuvant trial of metformin (MET) vs placebo (PLAC) in early breast cancer (BC): Results of the primary efficacy analysis (clinical trials.gov NCT01101438)Pamela J. Goodwin,Bingshu E. Chen,Karen A. Gelmon,Timothy J. Whelan,Marguerite Ennis,Julie Lemieux,Jennifer A. Ligibel,Dawn L. Hershman,Ingrid A. Mayer,Timothy J. Hobday,Judith M. Bliss,Priya Rastogi,Manuela Rabaglio-Poretti,Som D. Mukherjee, Robert R. Mackey,Vandana G. Abramson, Conrad Oja,Robert Wesolowski,Alastair M. Thompson,Daniel W. Rea, Paul M. Stos,Lois E. Shepherd,Vuk Stambolic,Wendy R. ParulekarCANCER RESEARCH（2022）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
